CA2061197A1 - Salicyloyl carnitine and process for its preparation - Google Patents
Salicyloyl carnitine and process for its preparationInfo
- Publication number
- CA2061197A1 CA2061197A1 CA 2061197 CA2061197A CA2061197A1 CA 2061197 A1 CA2061197 A1 CA 2061197A1 CA 2061197 CA2061197 CA 2061197 CA 2061197 A CA2061197 A CA 2061197A CA 2061197 A1 CA2061197 A1 CA 2061197A1
- Authority
- CA
- Canada
- Prior art keywords
- carnitine
- salicyloyl
- preparation
- vis
- trimethylarnmonio
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- PHIQHXFUZVPYII-ZCFIWIBFSA-O (R)-carnitinium Chemical compound C[N+](C)(C)C[C@H](O)CC(O)=O PHIQHXFUZVPYII-ZCFIWIBFSA-O 0.000 title 1
- 229960004203 carnitine Drugs 0.000 title 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 abstract 2
- RZNHSEZOLFEFGB-UHFFFAOYSA-N 2-methoxybenzoyl chloride Chemical compound COC1=CC=CC=C1C(Cl)=O RZNHSEZOLFEFGB-UHFFFAOYSA-N 0.000 abstract 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 abstract 1
- JXXCENBLGFBQJM-FYZOBXCZSA-N [(2r)-3-carboxy-2-hydroxypropyl]-trimethylazanium;chloride Chemical compound [Cl-].C[N+](C)(C)C[C@H](O)CC(O)=O JXXCENBLGFBQJM-FYZOBXCZSA-N 0.000 abstract 1
- 229960001138 acetylsalicylic acid Drugs 0.000 abstract 1
- 229960003237 betaine Drugs 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000002496 gastric effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 230000001988 toxicity Effects 0.000 abstract 1
- 231100000419 toxicity Toxicity 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/22—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated the carbon skeleton being further substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Novel 3-(2-hydroxybenzoyloxy)-4-(trimethylarnmonio)-butyric acid betaine and its pharmaceutically acceptable salts are disclosed. The compounds are distinguished by high water solubility, minimum toxicity, and good gastric tolerance vis-a-vis acetylsalicylic acid and can be prepared from carnitine hydrochloride and o-methoxybenzoyl chloride.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA 2061197 CA2061197C (en) | 1992-02-13 | 1992-02-13 | Salicyloyl carnitine and process for its preparation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA 2061197 CA2061197C (en) | 1992-02-13 | 1992-02-13 | Salicyloyl carnitine and process for its preparation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2061197A1 true CA2061197A1 (en) | 1993-08-14 |
| CA2061197C CA2061197C (en) | 2002-04-30 |
Family
ID=4149253
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA 2061197 Expired - Fee Related CA2061197C (en) | 1992-02-13 | 1992-02-13 | Salicyloyl carnitine and process for its preparation |
Country Status (1)
| Country | Link |
|---|---|
| CA (1) | CA2061197C (en) |
-
1992
- 1992-02-13 CA CA 2061197 patent/CA2061197C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CA2061197C (en) | 2002-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2171275A1 (en) | Stilbene derivatives and pharmaceutical compositions containing them | |
| FI942092A7 (en) | Government-approved product | |
| MY110110A (en) | Pharmaceuticals in the treatment of gastrointestinal disorders, cardiovascular disorders and cns disorders | |
| CA2269807A1 (en) | Substituted aminoalkanephosphonic acids | |
| CA2333004A1 (en) | Formoterol polymorphs | |
| WO2001072728A3 (en) | Novel piperazine derivatives | |
| CA2110693A1 (en) | Amino acid derivative anticonvulsant | |
| CA2142869A1 (en) | Trifluoromethylpyrroloindolecarboxylic acid ester and process for production thereof | |
| AU7672294A (en) | Compositions and methods for the administration of delta-aminolevulinic acid | |
| CA2228281A1 (en) | Use of l-carnitine and acyl l-carnitines for lowering ceramide levels | |
| RU92016595A (en) | SUBSTITUTED THIAZOLYL AND SUBSTITUTED PYRIDINYL DERIVATIVES, PHARMACEUTICAL COMPOSITION AND METHOD FOR PRODUCING THEM | |
| WO2002102787A3 (en) | Novel sulfonic acid derivatives | |
| ITFI930030A0 (en) | PYRROL-AMIDIN COMPOUNDS, AND THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, PREPARATION PROCESSES AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM-NO. | |
| EP0645391A3 (en) | Aminobenzoic acid derivatives. | |
| CA2340054A1 (en) | Oral administration form for pyridin-2-ylmethylsulfinyl-1h-benzimidazoles | |
| UA37311C2 (en) | Compound for treating sexual dysfunction and pharmaceutical composition | |
| CA2204747A1 (en) | New azo derivatives of 5-aminosalicylic acid | |
| EP0647229A1 (en) | DIAMINE SALTS OF CLAVULANIC ACID. | |
| ES8105969A1 (en) | Fluorinated methyl beta-alanine derivatives, their preparation and pharmaceutical compositions containing them. | |
| CA2200742A1 (en) | Quinoxaline derivatives useful in therapy | |
| EP0818439A3 (en) | Imide derivatives | |
| GR3020190T3 (en) | Diclofenac choline salt, a method for the preparation thereof and pharmaceutical compositions containing it | |
| CA2061197A1 (en) | Salicyloyl carnitine and process for its preparation | |
| AU9004591A (en) | 1,4-benzothiazine-2-acetic acid derivatives, processes for production thereof | |
| ES8305717A1 (en) | Substituted 2-amino-3,4-dihydro-pyridine derivatives, process for their preparation and their use in medicines. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKLA | Lapsed |